Research Topics
Species | Susumu OgawaSummaryAffiliation: Tohoku University Country: Japan Publications
| Collaborators
|
Detail Information
Publications
Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathySusumu Ogawa
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University School of Medicine, Sendai, Japan
Hypertens Res 30:325-34. 2007..Even among patients treated with an ACEI and/or ARB, lowering BP is important...
Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressureSusumu Ogawa
Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital, 1 1 Seiryo machi, Aoba ku, Sendai 980 8574, Japan
Hypertension 56:471-6. 2010..DG is an independent risk factor for the percentage change of ACR. MG is a predictor in type 2 diabetic patients of intima-media thickening, of increase of PWV, and of elevation of SBP...
Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathySusumu Ogawa
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Aoba ku, Sendai, Japan
Hypertens Res 31:1147-55. 2008....
Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetesSusumu Ogawa
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University School of Medicine, 1 1 Seiryo cho, Aoba ku, Sendai 980 8574, Japan
Clin J Am Soc Nephrol 3:362-8. 2008....
Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitorSusumu Ogawa
Division of Nephrology, Endocrinology and Hypertension, Tohoku University Hospital, Sendai, Japan
Clin Exp Pharmacol Physiol 33:477-9. 2006..Blood pressure levels in both groups were comparable. 5. In conclusion, additional therapy with spironolactone in ACEI treatment exerts a renoprotective, as well as cardioprotective, effect in hypertensive diabetes...
Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathySusumu Ogawa
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University School of Medicine, Sendai 980 8574, Japan
Hypertension 47:699-705. 2006..Our results may help to explain the clinical observation that ARB reduces urinary albumin excretion very efficiently in some patients but not in others...
Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague-Dawley ratsSatoshi Endo
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Tohoku University, Sendai, Japan
Hypertens Res 32:513-9. 2009..We conclude that OLM and HCTZ could be a useful combination for reduction of blood pressure even under high salt intake without changes in urinary oxidative stress levels...
Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed ratsQi Guo
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
Hypertens Res 35:48-54. 2012..These results indicate that losartan reverses HCTZ-exacerbated insulin resistance, which can be mediated through the modulation of muscular circulation in rats with impaired glucose metabolism...
Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulationChunyan Hu
Division of Nephrology, Tohoku University Graduate School of Medicine, Sendai, Japan
J Hypertens 30:1620-31. 2012..Studies were designed to determine the effects of a specific TCC blocker, R(-) efonidipine [R(-)EFO], on the regulation of renal circulation...
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetesSusumu Ogawa
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
Tohoku J Exp Med 223:133-5. 2011..The hypotensive effect is apparent with the alternate-day regimen of sitagliptin at a lower dose compared to the everyday medication...
Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive ratsXianguang Chen
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
Hypertens Res 36:361-7. 2013..These results suggest that MG-induced hypertension and cardio-renal injury and increased inflammation and carbonyl and oxidative stress, which were partially preventable by an ARB...
The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndromeMiho Senda
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai 980 8574, Japan
Endocr J 59:889-94. 2012....
Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetesTakefumi Mori
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
Clin Exp Pharmacol Physiol 39:125-31. 2012..Oxidative and/or carbonyl stress may be the next target of drug discovery to protect against salt-sensitive hypertension and associated end-organ damage...
Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley ratsQi Guo
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai 980 8574, Japan
J Hypertens 27:1664-71. 2009..The present study was designed to investigate whether methylglyoxal could directly induce insulin resistance and salt sensitivity in Sprague-Dawley rats...
[Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus]Honglan Xu
Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan
Nippon Jinzo Gakkai Shi 47:524-30. 2005..05, respectively) in consistent with previous reports. These results suggested that IP-10 may have an etiopathogenic role in type2 DM and diabetic nephropathy as one of the downstream effectors of proinflammatory cytokines...
Effects of the Great East Japan Earthquake and huge tsunami on glycaemic control and blood pressure in patients with diabetes mellitusSusumu Ogawa
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
BMJ Open 2:e000830. 2012..To examine the effects of a huge tsunami resulting from the Great East Japan Earthquake on blood pressure (BP) control and glycaemic control in diabetic patients...
Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodiesTsuneo Ishizuka
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University School of Medicine, 1 1 Seiryo cho, Aoba ku, Sendai 980 8574, Japan
Diabetes Res Clin Pract 84:e21-3. 2009....
Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidneyTsuneo Ishizuka
Department of Nephrology, Endocrinology, and Hypertension, Tohoku University Graduate School of Medicine, Sendai, Japan
Hypertens Res 26:929-36. 2003....
Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic NephropathySusumu Ogawa
Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Japan
Biomark Insights 4:97-102. 2009....
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazoneSusumu Ogawa
Division of Nephrology, Endocrinology and Vascular Biology, Tohoku University Graduate School of Medicine, Sendai 980 8574, Japan
J Clin Endocrinol Metab 88:3993-6. 2003..In conclusion, BNP levels are suggested to be a good marker of Pio-induced LVD, and the Pio treatment of DM2 patients with BNP levels above the normal limit should be carefully carried out by monitoring BNP levels...
